NEW YORK (GenomeWeb) – Merck KGaA today said that it will collaborate with Sysmex Inostics on the development of a RAS biomarker mutation test for metastatic colorectal cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.
Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.
The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.
A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.